The American Thoracic Society's International Conference (ATS) – one of the largest gatherings of pulmonary, critical care, and sleep medicine professionals in the world – was held May 13-18 in San Francisco, California.
In numerous interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) sessions, international pulmonary specialists discussed exciting topics.
What was discussed at ATS 2016 with regards to interstitial lung diseases and idiopathic pulmonary fibrosis?
Download the inIPF one pagers which provide an overview of the discussed topics at “ATS Keynote: IPF” and “Clinical Year in Review: ILD”.
Summary of ATS Keynote: IPF
Summary of Clinical Year in Review: ILD
If you would like to view the full report which includes real world experience with and new data on antifibrotics in IPF, please visit the product website.